CHEC, a community healthcare provider specialising in ophthalmology services for the NHS, has unveiled a groundbreaking glaucoma surgery service at Trafford Park, Manchester.
The new Minimally Invasive Glaucoma Surgery (MIGS) offers a cutting-edge approach that combines glaucoma treatment with cataract surgery. This technique uses advanced methods to reduce blockages at various pressure points within the eye, enhancing natural fluid drainage.
By improving fluid flow and incorporating a microscopic implant into the eye’s membrane, MIGS addresses both glaucoma and cataracts, minimising optic nerve damage and preserving vision, while supporting long-term eye health.
Following a successful trial of MIGS at select hospitals earlier this year, CHEC is expanding this service to Trafford Park and eight other hospitals across the UK, with plans to add more locations soon.
MIGS is less invasive than traditional glaucoma surgeries, leading to reduced risks and quicker recovery times for patients. It is generally recommended for those with mild to moderate glaucoma who have compromised fluid drainage.
Katie Davies, hospital manager at CHEC Trafford Park, said: “At CHEC, we recognise the importance of empowering our patients with knowledge about their treatment options, and know that managing glaucoma can be a significant aspect of a person’s health journey.
“MIGS provides a crucial solution to help prevent the progression of glaucoma and in turn, save the health of the optic nerve. It also has the potential to simplify postoperative care – as the eye’s natural drainage system is restored so quickly after surgery – and reduce the need for glaucoma eye drops.
“We’re pleased to now be able to offer MIGS services on behalf of the NHS in Trafford Park, bringing advanced treatment to the local community to improve patient choice, treatment outcomes and quality of life.”
